Key Takeaway: BioLife Solutions, Inc. has announced corrected call-in numbers for its upcoming Earnings Call scheduled for 4:30 PM ET. This update aims to ensure that participants can easily join the call. BioLife is recognized for its contributions to the cell and gene therapy market, providing essential tools and services.
Price reaction · baseline $22.36 (2025-05-08 close) · hit after-hours · 1 other BLFS headline(s) in the window, move may be shared
day 0 close
+4.2%
Market Sentiment Analysis
POSITIVE FACTORS
BioLife Solutions is a leading developer in the CGT market.
The company is facilitating the commercialization of new therapies.
Corrected call-in numbers enhance accessibility for investors.
Full Press Release Details
BOTHELL, Wash.,May 8, 2025/PRNewswire/ --BioLife Solutions, Inc.(Nasdaq:BLFS)("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, is announcing corrected call-in numbers for their Earnings Call this afternoon at4:30pm ET. If you are joining, please use 1-833-630-0431 if calling fromthe United Statesor 1-412-317-1808 if dialing internationally.
About BioLife Solutions
BioLife is a leading developer and supplier of cell processing tools and services for the CGT market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. For more information, please visitwww.biolifesolutions.com, and follow BioLife onLinkedInandX.